drugset / Trial / NCT02366091

Inflammation and Coronary Endothelial Function

NCT02366091

RandomizedFactorialTriple-blindOther

Summary

The investigators are studying whether anti-inflammatory agents can improve abnormal coronary artery function in patients with coronary artery disease (CAD) and abnormal coronary artery endothelial function.

Timeline

Start
2015-01
Primary completion
2020-08-01
Completion
2020-09-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.6 mg Oral
Subject Methotrexate Small molecule 15 mg Oral